FDA | Financial Buzz- Part 2

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

Rebecca Urena09/23/202109/23/2021

2123

The Food and Drug Administration has granted emergency use authorization to Pfizer (NYSE: PFE) and BioNtech for its Covid-19 booster shots in people 65 years and older as well...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: RenovoRx, Inc. (NASDAQ: RNXT) 510(k) Clearance For RenovoCath Delivery System

financial buzz09/07/2021

1697

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ RenovoRx, Inc. Receives New 510(k) Clearance For RenovoCath Delivery System” RenovoRx, Inc. (NASDAQ: RNXT) surged over 40%...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment

financial buzz09/03/2021

1480

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Impel NeuroPharma, Inc Granted U.S. FDA Approval for its Acute Migraine Treatment” Impel NeuroPharma, Inc. (NASDAQ: IMPL)...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Chembio Diagnostics, Inc. (NASDAQ: CEMI) Distribution of Third-Party COVID-19 Test

financial buzz08/27/202108/27/2021

1761

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Chembio Diagnostics, Inc. Launches Commercial Distribution of Third-Party COVID-19 Antigen Test” Chembio Diagnostics, Inc. (NASDAQ: CEMI) climbed over...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Sesen Bio (NASDAQ: SESN) Nears the Potential Approval of Vicineum

financial buzz08/13/2021

2136

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Sesen Bio Strengthens Executive Leadership Team as the Company Nears the Potential Approval of Vicineum” Sesen Bio (NASDAQ:...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Notice of Allowance for Tollovid

financial buzz08/06/202109/14/2021

5822

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Receives Trademark Notice of Allowance from USPTO for Its 3CL Protease Inhibitor Dietary Supplement...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Receives Trademark Notice of Allowance from USPTO for Its 3CL Protease Inhibitor Dietary Supplement Tollovid™

financial buzz08/06/202108/06/2021

3485

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has received a notice of allowance from the US Patent & Trademark Office...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

FDA Grants Fast Track Destination for ERYASPASE to Treat Acute Lymphocytic Leukemia

Bryan Shin07/30/2021

2618

ERYTECH Pharma (NASDAQ: ERYP) has reported that the U.S. Food and Drug Administration has granted eryaspase Fast Track designation for treatment of acute lymphocytic leukemia in patients who have...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Immunome Inc (NASDAQ: IMNM) Antibody Cocktail Neutralizes Delta Variant

financial buzz07/20/2021

1572

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Immunome Inc Soars After Antibody Cocktail Neutralizes Delta variant in Pre-Clinical Testing” Immunome Inc. (NASDAQ: IMNM) surged over...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

Rebecca Urena07/13/202107/13/2021

4129

The Food and Drug Administration (FDA) revealed it would be placing a warning on the Johnson & Johnson Covid-19 (NYSE: JNJ) vaccine, as the shot has been associated with...

Tag: FDA

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

“The Buzz” Show: RenovoRx, Inc. (NASDAQ: RNXT) 510(k) Clearance For RenovoCath Delivery System

“The Buzz” Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment

“The Buzz” Show: Chembio Diagnostics, Inc. (NASDAQ: CEMI) Distribution of Third-Party COVID-19 Test

“The Buzz” Show: Sesen Bio (NASDAQ: SESN) Nears the Potential Approval of Vicineum

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Notice of Allowance for Tollovid

Breaking News: Todos Medical Receives Trademark Notice of Allowance from USPTO for Its 3CL Protease Inhibitor Dietary Supplement Tollovid™

FDA Grants Fast Track Destination for ERYASPASE to Treat Acute Lymphocytic Leukemia

“The Buzz” Show: Immunome Inc (NASDAQ: IMNM) Antibody Cocktail Neutralizes Delta Variant

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

ABOUT US

Tweets